Pseudorabies Virus Inhibits Expression of Liver X Receptors to Assist Viral Infection

Yi Wang1,2,3, Guo-Li Li1,2,3, Yan-Li Qi1,2,3

  • 1College of Veterinary Medicine, Henan Agricultural University, Zhengzhou 450046, China.

Viruses
|March 26, 2022
PubMed

Insights

Pseudorabies virus (PRV) infection lowers Liver X Receptor (LXR) levels. Activating LXRs inhibits PRV, impacting cholesterol metabolism and viral entry.

Area of Science:

  • Virology
  • Molecular Biology
  • Biochemistry

Background:

  • Pseudorabies virus (PRV) causes significant economic losses globally.
  • Liver X Receptors (LXRs) are key regulators of lipid homeostasis.
  • The role of LXRs in PRV infection remains unclear.

Purpose of the Study:

  • To investigate the interaction between PRV infection and LXR signaling.
  • To determine the effect of LXR modulation on PRV proliferation.
  • To elucidate the mechanism by which LXRs influence PRV entry.

Main Methods:

  • Quantitative real-time PCR and Western blotting to assess LXRα and LXRβ expression.
  • In vitro and in vivo experiments to evaluate PRV proliferation under LXR activation/inhibition.
  • Cholesterol level measurements and live-cell imaging to analyze clathrin-coated pit dynamics.
  • In vivo antiviral efficacy study using an LXR agonist (T0901317) in mice.

Main Results:

  • PRV infection downregulated LXRα and LXRβ expression both in vitro and in vivo.
  • LXR activation suppressed PRV proliferation, whereas LXR inhibition enhanced it.
  • LXR activation reduced cellular cholesterol, affecting clathrin-coated pit dynamics and PRV entry.
  • Cholesterol replenishment reversed the effects of LXR activation on viral entry.
  • T0901317 treatment protected mice against PRV infection.

Conclusions:

  • PRV infection modulates LXR expression and function.
  • LXR signaling plays a crucial role in controlling PRV proliferation.
  • PRV utilizes LXR-mediated cholesterol metabolism to facilitate viral entry and replication.
  • Targeting LXR pathways represents a potential therapeutic strategy against PRV.